First-Line Atezolizumab Effective in Bladder Cancer

    Cancer Discovery
    |June 23, 2016
    PubMed
    Summary

    PD-L1 inhibitor atezolizumab shows effectiveness in first-line treatment for advanced bladder cancer. Nearly 25% of patients ineligible for cisplatin achieved durable responses, indicating a promising therapeutic option.

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.9K
    Urinary Bladder01:23

    Urinary Bladder

    The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
    In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
    4.1K